• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病L1210细胞暴露于氟尿嘧啶后相关的细胞表面改变。

Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.

作者信息

Kessel D

出版信息

Cancer Res. 1980 Feb;40(2):322-4.

PMID:7356515
Abstract

Exposure of murine leukemia L1210 cells to graded doses of 5-fluorouracil for 24 hr led to a progressive increase in cell surface hydrophobicity, inhibition of cell division, an an increased cell volume. Among the effects associated with fluorouracil treatment were inhibition of thymidylate synthetase, decreased incorporation of leucine into glycoprotein, and an apparently increased incorporation of thymidine into DNA and of glucosamine into glycoprotein. The latter effects are believed to be caused by depleted metabolite pools. Short-term treatment of L1210 cells with the drug altered only levels of thymidylate synthetase. Cell surface changes therefore appear to be related to long-term effects of fluorouracil associated with impaired synthesis of membrane glycoprotein.

摘要

将鼠白血病L1210细胞暴露于不同剂量的5-氟尿嘧啶中24小时,会导致细胞表面疏水性逐渐增加、细胞分裂受到抑制以及细胞体积增大。与氟尿嘧啶处理相关的效应包括胸苷酸合成酶的抑制、亮氨酸掺入糖蛋白的减少,以及胸苷掺入DNA和葡糖胺掺入糖蛋白的明显增加。后一种效应被认为是由代谢物池的耗尽引起的。用该药物对L1210细胞进行短期处理仅改变了胸苷酸合成酶的水平。因此,细胞表面的变化似乎与氟尿嘧啶与膜糖蛋白合成受损相关的长期效应有关。

相似文献

1
Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.白血病L1210细胞暴露于氟尿嘧啶后相关的细胞表面改变。
Cancer Res. 1980 Feb;40(2):322-4.
2
The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.衣霉素和D-葡萄糖胺对L1210白血病细胞的生化及超微结构影响
J Cell Physiol. 1983 Feb;114(2):162-72. doi: 10.1002/jcp.1041140204.
3
Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
Cancer Res. 1983 Apr;43(4):1669-74.
4
Studies on a cell line derived from the L1210 murine leukemia with altered surface properties and decreased capacity for tumor production.对源自L1210小鼠白血病且具有改变的表面特性和降低的肿瘤产生能力的细胞系的研究。
Cancer Res. 1974 Mar;34(3):603-8.
5
Inhibitory effects of phytohemagglutinin isolectins L4 and E4 on L1210 cells.植物血凝素同工凝集素L4和E4对L1210细胞的抑制作用。
Cancer Res. 1978 Jun;38(6):1677-87.
6
In vitro biological evaluation of the R and S isomers of 1-(Tetrahydrofuran-2-yl)-5-fluorouracil.1-(四氢呋喃-2-基)-5-氟尿嘧啶R和S异构体的体外生物学评价
Cancer Res. 1975 May;35(5):1301-4.
7
Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
Cancer Res. 1978 Aug;38(8):2325-31.
8
Alterations of membrane constituents in carcinomas and drug resistant tumour cells.
Arch Geschwulstforsch. 1978;48(8):770-82.
9
Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
Cancer Res. 1980 Mar;40(3):598-603.
10
A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
Cancer Res. 1979 Apr;39(4):1396-404.

引用本文的文献

1
The separation of cells and organelles by partitioning in two-polymer aqueous phases.通过在双聚合物水相中的分配来分离细胞和细胞器。
Biochem J. 1981 Apr 15;196(1):1-10. doi: 10.1042/bj1960001.
2
Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.正常受试者和间质性肺疾病患者肺泡巨噬细胞纤溶酶原激活物的产生。
Thorax. 1988 Jul;43(7):508-15. doi: 10.1136/thx.43.7.508.
3
Clinical pharmacology of 5-fluorouracil.5-氟尿嘧啶的临床药理学
Clin Pharmacokinet. 1989 Apr;16(4):215-37. doi: 10.2165/00003088-198916040-00002.
4
Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.(αS,5S)-2-氨基-3-氯-4,5-二氢-5-异恶唑乙酸与5-氟尿嘧啶在P388白血病中协同作用的生化机制。
Cancer Chemother Pharmacol. 1985;15(1):44-8. doi: 10.1007/BF00257293.